Accendra Health (ACH) Liabilities and Shareholders Equity (2009 - 2026)
Accendra Health (ACH) reported Liabilities and Shareholders Equity of $2.4 billion for Q1 2026, down 50.25% year-over-year from $4.9 billion in Q1 2025, and down 1.46% quarter-over-quarter from $2.5 billion in Q4 2025.
Accendra Health (ACH) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $2.4 billion in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $2.4 billion, down 50.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 billion (down 34.37% YoY), and the FY2025 annual result was $2.5 billion, down 47.34% from the prior year.
- Liabilities and Shareholders Equity eased to $2.4 billion in Q1 2026 per ACH's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $5.7 billion in Q1 2022 and troughed at $2.4 billion in Q1 2026.
- A 5-year average of $4.8 billion and a median of $5.1 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 68.34% in 2022, then tumbled 50.25% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $5.4 billion in 2022, then fell by 5.44% to $5.1 billion in 2023, then fell by 8.58% to $4.7 billion in 2024, then tumbled by 47.34% to $2.5 billion in 2025, then fell by 1.46% to $2.4 billion in 2026.
- Business Quant data shows ACH's Liabilities and Shareholders Equity at $2.4 billion in Q1 2026, $2.5 billion in Q4 2025, and $4.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 212.04 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 82.32 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 81.65 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 56.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 11.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.42 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 72.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 310.22 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 62.37 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42 Bn |
| Dec 31, 2025 | 2.45 Bn |
| Sep 30, 2025 | 4.04 Bn |
| Jun 30, 2025 | 4.15 Bn |
| Mar 31, 2025 | 4.86 Bn |
| Dec 31, 2024 | 4.66 Bn |
| Sep 30, 2024 | 5.08 Bn |
| Jun 30, 2024 | 5.30 Bn |
| Mar 31, 2024 | 5.21 Bn |
| Dec 31, 2023 | 5.09 Bn |
| Sep 30, 2023 | 5.12 Bn |
| Jun 30, 2023 | 5.29 Bn |
| Mar 31, 2023 | 5.31 Bn |
| Dec 31, 2022 | 5.39 Bn |
| Sep 30, 2022 | 5.54 Bn |
| Jun 30, 2022 | 5.56 Bn |
| Mar 31, 2022 | 5.71 Bn |
| Dec 31, 2021 | 3.54 Bn |
| Sep 30, 2021 | 3.58 Bn |
| Jun 30, 2021 | 3.59 Bn |